The appropriateness of three animal models in mimicking pathophysiology and symptoms of Alzheimer's disease was assessed. Behavioural tasks provided measures of cognitive function, affective behaviour and locomotor ability. Adult and aged transgenic mice, expressing the C104 fragment of the human $ beta$-Amyloid Precursor Protein, displayed increased anxiety by seven months of age in the Thatcher-Britton Novelty Conflict paradigm, memory impairments in the Forced Alternation T-Maze, the Porsolt Forced Swim test and the Recognition test, and decreased hippocampal acetylcholinesterase staining. BIBN99, a muscarinic M2-antagonist that increases release of acetylcholine, failed to ameliorate these changes. Apolipoprotein E deficient mice showed...
In the present study, we used a new training paradigm in the intelliCage automatic behavioral assess...
Alzheimer disease (AD) is the leading cause of dementia among elderly. Currently, no effective treat...
Evaluation of the efficacy of novel therapeutics for potential treatment of Alzheimer's disease (AD)...
Our understanding of the underlying biology of Alzheimer's disease (AD) has been steadily progressin...
Mouse models have been used in research about the pathogenesis and possible prevention or treatment ...
Our understanding of the underlying biology of Alzheimer's disease (AD) has been steadily progressin...
The pathophysiology of chronic neurodegenerative diseases, as Alzheimer's diseases, has remained ina...
Alzheimer disease (AD) is the leading cause of dementia among elderly. Currently, no effective treat...
In order to better understand animal models of Alzheimer's disease, novel phenotyping strategies hav...
With the increased morbidity and unclear etiology of Alzheimer’s disease (AD), there is an urgent ne...
Behavioral characterization of animal models for Alzheimer\u27s Disease is critical for the developm...
Alzheimer disease (AD) is the leading cause of dementia among elderly. Currently, no effective treat...
Behavioral characterization of animal models for Alzheimer\u27s Disease is critical for the developm...
Behavioral characterization of animal models for Alzheimer\u27s Disease is critical for the developm...
In the present study, we used a new training paradigm in the intelliCage automatic behavioral assess...
In the present study, we used a new training paradigm in the intelliCage automatic behavioral assess...
Alzheimer disease (AD) is the leading cause of dementia among elderly. Currently, no effective treat...
Evaluation of the efficacy of novel therapeutics for potential treatment of Alzheimer's disease (AD)...
Our understanding of the underlying biology of Alzheimer's disease (AD) has been steadily progressin...
Mouse models have been used in research about the pathogenesis and possible prevention or treatment ...
Our understanding of the underlying biology of Alzheimer's disease (AD) has been steadily progressin...
The pathophysiology of chronic neurodegenerative diseases, as Alzheimer's diseases, has remained ina...
Alzheimer disease (AD) is the leading cause of dementia among elderly. Currently, no effective treat...
In order to better understand animal models of Alzheimer's disease, novel phenotyping strategies hav...
With the increased morbidity and unclear etiology of Alzheimer’s disease (AD), there is an urgent ne...
Behavioral characterization of animal models for Alzheimer\u27s Disease is critical for the developm...
Alzheimer disease (AD) is the leading cause of dementia among elderly. Currently, no effective treat...
Behavioral characterization of animal models for Alzheimer\u27s Disease is critical for the developm...
Behavioral characterization of animal models for Alzheimer\u27s Disease is critical for the developm...
In the present study, we used a new training paradigm in the intelliCage automatic behavioral assess...
In the present study, we used a new training paradigm in the intelliCage automatic behavioral assess...
Alzheimer disease (AD) is the leading cause of dementia among elderly. Currently, no effective treat...
Evaluation of the efficacy of novel therapeutics for potential treatment of Alzheimer's disease (AD)...